A single-and multiple-dose, open-label, Phase I study to investigate the safety, tolerability, pharmacokinetics, pharmacodynamics, and immunogenicity of subcutaneously administered RO7204239 in adult participants with high body weight
-
Healthy Volunteers
For the latest version of this information please go to www.forpatients.roche.com